Crossmark

Specific Anti-IIa Activity is a Key Indicator of Safety and Efficacy in Validation of Biosimilarity of Unfractioned Heparin Preparations

Crossref DOI link: https://doi.org/10.1007/s10517-015-2782-3

Published Online: 2015-02-24

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mironov, A. N.

Goryachev, D. V.

Garvishina, E. V.

Niyazov, R. R.

Ivanova, O. Yu.
License Information

Text and Data Mining valid from 2015-02-01